bioMérieux Specific Diagnostics Acquisition 2022

bioMérieux presents the acquisition of Specific Diagnostics, a San Jose-based diagnostic company specializing in rapid antimicrobial susceptibility testing (AST) and blood culture systems. The acquisition, dated April 12, 2022, integrates Specific Diagnostics' FDA-approved diagnostic platform into bioMérieux's portfolio, expanding rapid microbiology testing capabilities.